We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.

ATENZA methylphenidate hydrochloride 27mg prolonged-release tablets (Spain)

Section 19A approved medicine

Phone

1800 195 055

Approved until

31 January 2026

Status

Current

Medicines in short supply/unavailable

CONCERTA methylphenidate hydrochloride 27mg modified release tablet bottle - ARTG 124502
METHYLPHENIDATE-TEVA XR methylphenidate hydrochloride 27 mg modified release tablet bottle - ARTG 370911

Indication(s)

Indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Treatment should be commenced by a specialist.

Images